BridgeMD
Tests treatment safety and results for Myasthenia Gravis
Official title The Effectiveness of Bu Zhong Yi Qi Tang in Patients with Myasthenia Gravis
ClinicalTrials.gov ID: NCT06881173
What this study is testing
What is Bu Zhong Yi Qi Tang?
Bu Zhong Yi Qi Tang is an investigational medicine, being studied as a potential treatment for myasthenia gravis.
Also referred to as TE202208013.
Plain-language explanation of the investigational treatment - it is being studied and is not an approved or proven therapy. The study team can confirm the details.
- What it's testing
- Research Background: According to the Myasthenia Gravis Foundation of America (MGFA, 2015), the estimated prevalence of myasthenia gravis is 14-20 per 100,000 people, with a higher prevalence in young female individuals compared to males. However, as individuals age, especially after the age of 50, the prevalence in males becomes higher than in females.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 20 and older
You may be able to join if
- Patients diagnosed with ocular myasthenia by a doctor
- Western medicine prescriptions only take oral Mestinon (Pyrido stigmine Bromide)
- Patients over 20 years old
- Can understand and understand Those who can speak Mandarin or Taiwanese
- those with a clear state of consciousness and no diagnosis of mental illness
You likely can't join if
- Patients with liver failure or kidney failure
- Allergy symptoms to traditional Chinese medicine, such as skin itching and redness
- Patients with malignant tumors
- Patients currently undergoing radiotherapy and chemotherapy
- Pregnant
- Cardiac rhythm device implementer
See the full eligibility criteria
- Patients diagnosed with ocular myasthenia by a doctor
- Western medicine prescriptions only take oral Mestinon (Pyrido stigmine Bromide)
- Patients over 20 years old
- Can understand and understand Those who can speak Mandarin or Taiwanese
- those with a clear state of consciousness and no diagnosis of mental illness
- patients and their families who are willing to receive precise integrated treatment of traditional Chinese and Western medicine.
- Patients with liver failure or kidney failure
- Allergy symptoms to traditional Chinese medicine, such as skin itching and redness
- Patients with malignant tumors
- Patients currently undergoing radiotherapy and chemotherapy
- Pregnant
- Cardiac rhythm device implementer
The study team makes the final eligibility decision.
Where it's taking place
- Taipei, Taiwan
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 20 years and older. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Taipei, Taiwan. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.